ECM – Eye Health News

Warby Parker Posts Q3 Revenue Growth, Nods to Partnerships With Google and Samsung NEW YORK—Warby Parker Inc. (NYSE: WRBY) announced financial results yesterday for the third quarter ended September 30, 2025, posting net revenue of $221.7 million, an increase of $29.2 million or 15.2 percent, compared with the same period last year. Net income improved $9.9 million to $5.9 million versus the same period in 2024, the company…

Fielmann Group Sees Sales Growth in Q3 and Year-to-Date Results HAMBURG, Germany—Global eyewear provider the Fielmann Group (ETR: FIE) has announced financial results for the third quarter as well as nine months of 2025, reporting both quarterly and year-to-date growth. In the third quarter, group sales reached €618 million, an increase of 3 percent over the same quarter last year, and topline growth in constant…

STAAR Surgical Reports Third Quarter Results LAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA), a leading developer of phakic intraocular lenses with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, has reported results for the third quarter ended September 26, 2025.

RxSight, Inc. Releases 2025 Third Quarter Results, Narrows Full-Year Revenue Range ALISO VIEJO, Calif.—RxSight, Inc., (Nasdaq: RXST) an ophthalmic medical device company focused on improving vision after cataract surgery, on Wednesday announced financial results for the three months ended September 30, 2025.

More Than Half of Small Business Owners Worry About Taxes, Study Shows NEW YORK—More than half of small business owners are concerned about implementing the right tax structure and how they can save money on taxes, according to new data from Lili’s Accountant AI, an AI-powered tool designed for small business owners that provides on-demand accounting and financial advice through a chat-based interface. The questions asked through…

Disease of 1,000 Faces Shows How Science Is Tackling Immunity’s Dark Side Doctor after doctor misdiagnosed or shrugged off Ruth Wilson’s rashes, swelling, fevers and severe pain for six years. She saved her life by begging for one more test in an emergency room about to send her home, again, without answers. That last-ditch test found the Massachusetts woman’s kidneys were failing. The culprit? Her immune system…

1 in 10 Worldwide Report Nonceliac Gluten/Wheat Sensitivity Self-reported nonceliac gluten/wheat sensitivity (NCGWS) affects about 1 in 10 people worldwide, and the first comprehensive global study on its prevalence and clinical characteristics has found a strong association with female sex, psychological distress and irritable bowel syndrome (IBS).

National Vision Reports 2025 Third Quarter Revenue Growth, Raises Full-Year Guidance DULUTH, Ga.—National Vision Holdings, Inc. (NASDAQ: EYE), one of the largest optical retail companies in the U.S., yesterday announced financial results for its third quarter ending September 27, 2025, reporting growth for both the quarter and year-to-date. Net revenue in the third quarter increased 7.9 percent to $487.3 million, driven by what the company said…

Tarsus Achieves Strong Third Quarter Financial Results, Driven by Growing Xdemvy Prescriptions IRVINE, Calif.—Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) a biopharmaceutical company focused on the development and commercialization of therapeutic eyecare treatments, has announced financial results for the third quarter ended September 30, 2025. Net product sales for the quarter were reported at $118.7 million, compared with $48.1 million for the same period in 2024, driven by more…

Alcon Reiterates Value of STAAR Merger Proposal in Investor Discussion Materials GENEVA, Switzerland—Alcon (SIX/NYSE: ALC), a global leader in eyecare, announced on November 4 that it has filed an investor presentation in support of its proposed acquisition of STAAR Surgical Company (NASDAQ: STAA) with the U.S. Securities and Exchange Commission (SEC).

LENZ Therapeutics Shares Third Quarter Financial Results, Highlights VIZZ Approval and Launch SAN DIEGO—LENZ Therapeutics, Inc. (Nasdaq: LENZ), the pharmaceutical company focused on the commercialization of recently FDA-approved VIZZ (aceclidine ophthalmic solution) 1.44%, has announced financial results for the third quarter ending September 30, 2025.

The University of Waterloo Develops New Differential Acuity Test for Children Under Three Years Old WATERLOO, Ontario—Researchers at the University of Waterloo announced their ongoing development and trials of the Waterloo Differential Acuity Test, or WatDAT, a new eye test based on age-appropriate tasks that can lead to earlier detection and treatment of vision problems in children as young as 18 months. Researchers said this test could enable earlier detection…

Cancer Drug Made 20,000 Times More Potent in Breakthrough A common cancer drug has been restructured to make its cancer cell killing abilities up to 20,000 times more effective while also reducing its toxicity. Researchers from the Northwestern University in Illinois re-engineered the structure of the commonly-used chemotherapy drug 5-fluorouracil (5FU) into that of a "spherical nucleic acid" (SNA)—a nanostructure that weaves the drug…

Safilo Group Shows Strong Margins, Steady Sales Growth in Third Quarter and 9-Month UpdatePADUA, Italy—Safilo Group S.p.A. (SFLG.MI) has announced financial results for the third quarter and first nine months of 2025, demonstrating net sales of €220.8 million and €758.4 million, respectively, up 2.1 percent and 2.2 percent constant exchange rates. Gross profits were reported at €131.7 million for Q3, a 1.2 percent decrease compared with the same…

Ocular Therapeutix Reports 2025 Third Quarter Revenue DecreaseBEDFORD, Mass.—Ocular Therapeutix Inc. (NASDAQ: OCUL), an integrated biopharmaceutical company in the retina space, yesterday reported financial results for the third quarter and nine months ended September 30, 2025.

The University of Waterloo Develops New Differential Acuity Test for Children Under Three Years OldWATERLOO, Ontario—Researchers at the University of Waterloo announced their ongoing development and trials of the Waterloo Differential Acuity Test, or WatDAT, a new eye test based on age-appropriate tasks for children as young as 18 months.

AI in Eye Care: What an AI-Enhanced Evidence-Based Medicine Model Might Mean to the U.S. Health Care SystemAI has the potential to change many parts of our global community. However, maybe none as far-reaching as its potential impact on health care systems worldwide. This article will focus on the possibilities and challenges of building an enhanced evidence-based medical model to improve the U.S. health care system. This change will undoubtedly require patients,…

Maldives Becomes Only Nation With Generational Smoking BanThe Maldives began implementing a smoking ban Saturday on anyone born on or after January 2007, becoming the only nation with a generational prohibition on tobacco, the Health Ministry said.

What Taking Melatonin Could Reveal About Your Heart HealthTaking melatonin for long periods of time could be a sign of underlying heart problems. Long-term use of the popular over-the-counter sleep aid has been linked to a higher risk of heart failure and early death in adults with insomnia, according to research released Monday.

First Clinical Trial of Pig Kidney Transplants Gets UnderwayThe first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives. United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study's initial transplant was performed successfully at NYU Langone Health in New York City.

U.S. Department of Veterans Affairs to Recognize Optometrists at Physician-Level Pay TableWASHINGTON—The U.S. Department of Veterans Affairs (VA) published new regulations last week that will include doctors of optometry in the VA’s physician-level pay table, a change the American Optometric Association (AOA) said places them alongside physicians, dentists and podiatrists, in a “major win for the profession.” The Federal Register notice, posted on October 24, said…

Kalaris Therapeutics Appoints Matthew Gall as Chief Financial OfficerPALO ALTO, Calif.—Kalaris Therapeutics, a clinical-stage biopharmaceutical company focused on treatments for common retinal diseases, announced the expansion of its leadership team with the appointment of Matthew Gall, MBA, as its new chief financial officer (CFO).

AAVantgarde Closes $141 Million Series B Financing Round to Advance Clinical ProgramsLONDON and MILAN—AAVantgarde Bio, a clinical-stage, biotechnology company developing therapies for inherited retinal diseases (IRDs), has announced the successful closing of a $141 million Series B financing round.

Obstructive Sleep Apnea May Be Linked to Microbleeds in the BrainMaybe you know you snore like a bear, but you don’t feel much urgency to look into it. Or maybe you have been told to wear a continuous positive airway pressure, or CPAP, machine for sleep apnea, but it is just so cumbersome. A new study shows that it is important to take obstructive sleep…

The 'Boogeyman' in Our Food: Fears vs. Facts About LeadWe know high levels of lead in your blood can be harmful, and recent headlines suggest the heavy metal has gotten into our food supply. In the last 18 months, it's been found in protein powders, cinnamon, applesauce, lunch kits and dark chocolate. There's a reason for that: Lead is in our food. In fact,…

Chemotherapy Drug Shortages Become Cancer-Care RealityIntermittent shortages of various injectable chemotherapy drugs have become a regular part of cancer care, with oncology practices reporting that despite their best efforts to mitigate supply challenges, shortages can be detrimental to patient care.

EssilorLuxottica Invests CA$1.5 Million in Canadian Optometry SchoolsMONTREAL—EssilorLuxottica, has announced a multi-year pledge of more than CA$1.5 million to The Université de Montréal – École d’Optométrie and the University of Waterloo School of Optometry and Vision Science. In making the announcement, the company noted that the pledge aims to support both schools with enhanced research capacity, modernized clinical infrastructure, and stronger industry–academic…

The Vision Council Foundation Provides Free Eye Exams to Orlando Students in Partnership With 20/20 OnsiteALEXANDRIA, Va.—The Vision Council Foundation recently partnered with 20/20 Onsite to bring eyecare services at no cost to students at CrossTown 119, a Title I school in Orlando, Fla., serving students in grades K-8.

Eli Lilly’s Weight Loss and Diabetes Drug Tops Keytruda as World’s Best-Selling MedicineMerck, which has claimed bragging rights as the maker of the world’s best-selling drug, Keytruda, since 2023, has officially been surpassed by Eli Lilly. Lilly’s tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for obesity, saw $10.1 billion in sales in the third quarter, the pharma giant said Thursday, bringing year-to-date sales of…

Circadian Health Key in Cardiometabolic Disease Prevention, American Heart Association SaysCircadian rhythm plays a fundamental role cardiometabolic health, but too many Americans do things to undermine their body’s natural cycles, according to a new scientific statement from the American Heart Association.

Prevent Blindness Offers New Resources as Part of November’s Diabetes Related Eye Disease MonthCHICAGO—Prevent Blindness, a nonprofit eye health organization, has announced it is offering new resources to the public as part of its Diabetes Related Eye Disease Month in November. According to the study titled Prevalence of Diabetic Retinopathy in the US in 2021, approximately one in four Americans ages 40 and older with diabetes have diabetic…

Oculis Announces Oversubscribed $110 Million Financing Plan to Accelerate Development of PrivosegtorZUG, Switzerland—Oculis Holding AG (Nasdaq: OCS; XICE: OCS), a global biopharmaceutical company, announced pricing of an aggregate of 5,432,098 of its ordinary shares at $20.25 per share, raising $110 million in gross proceeds.

Celularity and DefEYE, Inc. Form Partnership to Advance Growth of Regenerative Therapies in EyecareFLORHAM PARK, N.J.—Celularity Inc. (Nasdaq: CELU), a company focused on regenerative and cellular medicine for age-related and degenerative diseases, has formed a strategic partnership with DefEYE, Inc., a new, privately-held ophthalmic product and technology company.

Review of Ophthalmology: Back to Basics—The Language of PhacoIn 1967 Charles Kelman, MD, introduced ophthalmology to phacoemulsification, and the procedure is still going strong for most cataract cases. In his original paper on the subject, Dr. Kelman suggests a method of dissolving, emulsifying and aspirating a nuclear cataract. However, the principle of dissolving a nucleus has somewhat changed and can now better be…

Canada Is Poised to Lose Its Measles Elimination Status—And the U.S. Could, TooMonday marks a full year of continuous measles transmission in Canada, a milestone that’s poised to set the country back decades on a global health commitment. Ongoing transmission in the United States puts it among a group of countries that also face scrutiny from international leaders and are at risk of a similar fate.

Teens Who Use Weed Before Age 15 Have More Trouble Later, a Study FindsTeens who start using cannabis before age 15 are more likely to use the drug often later in their lives. They are also more likely to develop mental and physical health problems in young adulthood compared to their peers who did not use the drug in adolescence.

FDA Launches Effort to Ease Approval Pathway for BiosimilarsFederal regulators are trying to make it easier to develop cheaper alternatives to biologics that many Americans depend on to treat autoimmune diseases or cancers. The FDA said Wednesday it has released guidance to simplify studies for biosimilars and cut unnecessary testing.

Bausch + Lomb Reports Revenue Growth in 2025 Third Quarter, Confirms Full-Year OutlookVAUGHAN, Ontario—Eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced third-quarter financial results on Wednesday for the three months ending September 30, 2025. The company reported total revenue of $1.281 billion for the third quarter, an increase of $85 million, or 7 percent, compared with $1.196 billion in the third quarter of 2024. This…

Glaukos Reports Record Net Sales in Third Quarter, Raises 2025 Full-Year GuidanceALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company, yesterday announced financial results for the third quarter ended September 30, 2025.

'Fertility Tourism' Booming as U.S. Couples Seek Affordable Treatments AbroadAfter two years of trying to get pregnant, Maggie Quinn and Ricardo Escobar faced a financial obstacle they hadn't expected: the cost of in vitro fertilization in the United States.

Sleep Scientists’ Tips for a Healthier Time ChangeOur internal body clock influences nearly every aspect of our health, including hormones, metabolism, immune function and brain activity. And it doesn’t like being reset.

EssilorLuxottica Appoints Brandi Marsh as SVP of Human Resources, Professional Solutions North AmericaNEW YORK—EssilorLuxottica announced it has appointed Brandi Marsh to the new position of senior vice president of human resources for Professional Solutions in North America, effective immediately. The company said Marsh will oversee HR strategy across Professional Solutions North America, including talent development, organizational design, employee engagement and sense of belonging. Bringing more than 25…

Accessories Council and Jobson Publishing Announce Landmark Collaboration for Eyewear Design Week 2026 in New York CityNEW YORK—The Accessories Council (AC), publisher of AC Magazine, and Jobson Publishing, publisher of Vision Monday and 20/20 magazine, today announced a groundbreaking partnership to present a united and cohesive magazine, education platform and networking program titled “20/20 x AC, The Ultimate Guide to NYC Eyewear Design Week,” which is to take place March 5-8 in…

IDOC Opens Registration for The Connection 2026: 'The Future in Focus'ORLANDO, Fla.—IDOC, a community of optometric practice owners, has announced that registration is now open for The Connection 2026: “The Future in Focus,” taking place February 12–15, 2026, at the Rosen Shingle Creek Luxury Resort & Spa located here.

Application Period Opens for 2026 Golden Opportunity Award to Support Emerging OptometristsST. LOUIS—The AOA Foundation — Optometry Cares and PERC Alliance have announced that the application period is now open for the third annual Golden Opportunity Award, an initiative honoring the legacy of Dr. David Golden.

Sightview Appoints Scott Foster as Chief Financial OfficerDURHAM, N.C.—Sightview, an electronic health record and practice management company focused on eyecare, has appointed D. Scott Foster (Scott), CPA, MBA, as chief financial officer, effective immediately. Foster replaces Dustin Osbourn as CFO.

NextGen Healthcare and Eyefinity Align to Expand Offerings for ODs and Ophthalmologists

Women Reach Heart Health Goals With Less Exercise Than Men, New Study SuggestsWomen may need less exercise than men to gain similar protection against coronary heart disease, according to a new study published in Nature Cardiovascular Research. The findings come from an observational study of more than 85,000 adults in the United Kingdom who were followed for about seven years.

Obesity Rate Declining in U.S., Gallup Research IndicatesAfter peaking at a record high of 39.9 percent in 2022, the U.S. adult obesity rate has gradually declined to 37.0 percent in 2025. This is a statistically meaningful decrease representing an estimated 7.6 million fewer obese adults compared with three years ago. Meanwhile, diagnoses of diabetes—a lifetime disease that can be managed but not…

Geographic Clusters Show Uneven Cancer Screening in the U.S.An analysis of 3,142 U.S. counties revealed that county-level screening for breast, cervical, and colorectal cancer increased overall between 1997 and 2019; however, despite reduced geographic variation, persistently high-screening clusters remained in the Northeast, whereas persistently low-screening clusters remained in the Southwest.

Roger Federer Foundation Partners With OneSight EssilorLuxottica Foundation to Bring Vision Care to Zambian SchoolchildrenZURICH, Switzerland and LUSAKA, Zambia—The Roger Federer Foundation and the OneSight EssilorLuxottica Foundation announced the completion of their first joint outreach program in Zambia, bringing free vision care to thousands of schoolchildren. Timed to coincide with World Sight Day on October 9, the initiative provided vision screenings for more than 2,700 schoolchildren across community schools…

STAAR Surgical Postpones Shareholder Meeting on Alcon Acquisition for Second Time; New Vote Is Set for December 3GENEVA, Switzerland and LAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA) announced on Monday a second postponement of its special stockholder meeting concerning the planned merger with Alcon (SIX/NYSE: ALC). Last scheduled for November 6, 2025, at 8:30 a.m., PT, the meeting has been moved to December 3, 2025, at 8:30 a.m., PT, STAAR Surgical said.…

Optometry School Applications Rise for Second Year in a Row, ASCO Report RevealsROCKVILLE, Md.—The Association of Schools and Colleges of Optometry (ASCO) announced that for the second year in a row, its U.S. institutions received the highest number ever of applicants during the 2024-2025 Optometry Centralized Application Service (OptomCAS) application cycle.

BostonSight Appoints Dr. Karen Carrasquillo as Chief Innovation and Education OfficerNEEDHAM, Mass.—BostonSight, a nonprofit eye health care organization, announced today that Karen Carrasquillo, OD, Ph.D., FAAO, FSLS, FBCLA, has been appointed to the new role of chief innovation and education officer, effective immediately.

Eli Lilly Taps Eyecare Market With Definitive Agreement to Acquire Adverum BiotechnologiesINDIANAPOLIS and REDWOOD CITY, Calif.—Eli Lilly and Company (NYSE: LLY) and Adverum Biotechnologies, Inc. (Nasdaq: ADVM) have announced a definitive agreement for Lilly to acquire Adverum Biotechnologies, Inc.

New Menopause Drug to Target Hot Flashes Without Hormones Gets FDA ApprovalThe U.S. Food and Drug Administration has approved another once-a-day pill that works without hormones to treat moderate to severe hot flashes in menopausal women, drugmaker Bayer said Friday.

Despite the Hoopla, Vaccines Should Be in Reach This Cough-and-Cold SeasonFor people whose autumn agenda includes getting vaccinated against respiratory diseases—COVID, flu, and, for some, respiratory syncytial virus (RSV)—this year may be surprisingly routine.

The Appendicitis Dilemma: Surgery or a Simpler Solution?At first glance, the results of a recent meta-analysis published in JAMA Pediatrics would indicate immediately operating on a child is the most effective treatment for uncomplicated acute appendicitis. But researchers and other experts say patients and families may appreciate the chance to avoid hospitalization with antibiotic treatment.

Registration Is Now Open for Vision Monday's 2026 Leadership Summit, ‘Resilience Rising,’ in Orlando on March 11NEWARK, N.J.—Registration is now open for VM's 2026 Leadership Summit, which will be held in Orlando, Fla., on Wednesday, March 11, just ahead of Vision Expo. The program for the VM Summit is titled, "Resilience Rising: Future-Proofing Your Business for the 21st Century." Early bird tickets and registration have a deadline of 11:59 p.m. ET…

Registration Is Now Open for Vision Monday's 2026 Leadership Summit, ‘Resilience Rising,’ in Orlando on March 11NEWARK, N.J.—Registration is now open for VM's 2026 Leadership Summit, which will be held in Orlando, Fla., on Wednesday, March 11, just ahead of Vision Expo. The program for the VM Summit is titled, "Resilience Rising: Future-Proofing Your Business for the 21st Century." Early bird tickets and registration have a deadline of 11:59 p.m. ET…

Accreditation Council on Optometric Education Announces New LeadershipST. LOUIS—The Accreditation Council on Optometric Education (ACOE) has announced changes at the leadership level with the appointments of Julie DeKinder, OD, as chair, and Michelle Welch, OD, as vice chair. Former chair, G. Timothy Petito, OD, served as ACOE chair from 2022 to 2025 and will remain on the council as a member and…

David Troilo Inaugurated as the Fourth President of SUNY College of OptometryNEW YORK—During a recent ceremony at the New York City Bar Association, David Troilo, Ph.D., was formally inaugurated as the fourth president of the SUNY College of Optometry. Troilo has served as president since 2024 and brings over 17 years of leadership experience to the college.

Kathryn Colby, MD, Ph.D., NYU Langone Health Chair of Ophthalmology, Is Honored With Castroviejo Medal at AAO 2025ORLANDO, Fla.—NYU Langone Health has announced Kathryn A. Colby, MD, Ph.D., the Elisabeth J. Cohen, MD, professor and chair of the department of ophthalmology at NYU Grossman School of Medicine, was awarded the prestigious Castroviejo Medal from the Cornea Society.

Why Many Americans Who Are in the ER on Halloween End Up ThereNot all the scares and frights and bumps in the night are imaginary on Halloween. Each year, thousands of people land in the emergency room due to Halloween-related injuries.

Spare the IV: Study Finds Patients Like Oral Sedation and Office-Based Cataract SurgeryGiving patients oral diazepam before they undergo cataract surgery, instead of running an intravenous (IV) drip with sedatives, can provide adequate, complication-free sedation, a single-center study of more than 800 consecutive cases has found.

Music Meets Medicine as Parkinson's Patient Plays Clarinet During Brain SurgeryMusic met medicine when a patient played a clarinet solo as she underwent brain surgery for Parkinson's disease and proved that the treatment was working in real time.

STAAR Surgical’s Shareholder Vote on Planned Sale to Alcon Is Adjourned Until November 6GENEVA, Switzerland and LAKE FOREST, Calif.—Yesterday’s STAAR Surgical (NASDAQ: STAA) shareholder vote on Alcon's proposed acquisition of the company was adjourned until November 6, 2025, at 8:30 a.m. PT. STAAR Surgical and Alcon agreed to adjourn the October 23 special meeting of stockholders, in connection with STAAR’s merger agreement with Alcon, according to an announcement…

Topcon Healthcare Invests in Sanro Health to Connect Clinical and Imaging DataLA JOLLA, Calif. and MELBOURNE, Australia—Topcon Healthcare, Inc. has made a strategic investment in Sanro Health, Inc., a clinician-founded health technology company, according to an announcement from Sanro Health.

OneSight EssilorLuxottica Foundation and Vision To Learn Extend Partnership By Two YearsDALLAS—The OneSight EssilorLuxottica Foundation and Vision To Learn have announced a two-year extension of their eight-year partnership that provides children in need with vision care services to help them reach their full potential.

American Foundation for the Blind Names Bethany Johnson Vice President for ProgramsARLINGTON, Va.—The American Foundation for the Blind (AFB) announced it has appointed Bethany Johnson to the newly created role of vice president for programs, effective November 3.

Gum Disease Could Be Linked to an Increased Risk of Stroke and Brain Damage, Studies FindKeeping your mouth healthy may help keep your heart and brain healthy too, according to new research. In a study published Wednesday in Neurology Open Access, researchers found adults with gum disease may be more likely to have signs of damage to the brain's white matter than people without gum disease.

Drug Combo Boosts Prostate Cancer Survival by 40 Percent: What to KnowA new drug combination cuts the risk of death in people with advanced prostate cancer by 40 percent over eight years, according to unprecedented results of a drug treatment trial in men whose prostate cancer had returned.

Kering Eyewear Sees Single-Digit Revenue Growth in Q3 2025 as Group Revenue DeclinesPARIS—Kering Eyewear, part of the global luxury group Kering (KER.PA), reported revenue growth of 7 percent compared with the same period in 2024 during the group's third quarter earnings call yesterday. Overall, revenue from the Kering Eyewear and corporate segment amounted to €448 million in the third quarter of 2025, up 2 percent as reported…

Hoya Vision Care, Canada, and Centennial Optical Announce Multi-Year Investments in Canadian Optometry EducationMISSISSAUGA, Ontario—Hoya Vision Care, Canada, and Centennial Optical have announced plans for multi-year investments to support opticianry and optometry colleges and schools across Canada.

UAB Optometry, Safal Khanal, OD, Ph.D., Join $25 Million NIH-Funded Research Initiative to Combat Childhood MyopiaBIRMINGHAM, Ala.—The University of Alabama at Birmingham (UAB) School of Optometry announced it has joined a national network of 14 clinical research centers for a landmark $25 million National Institutes of Health (NIH)-funded initiative to combat childhood myopia.

NovaBay Pharmaceuticals Regains Compliance With NYSE American Continued Listing StandardsEMERYVILLE, Calif.—NovaBay Pharmaceuticals, Inc., a developer of eyecare, skin care and wound care products, announced that it has regained compliance with the NYSE American's continued listing standards.

Retinal Implant Restores Central Vision in Patients With Advanced AMD, Study Co-Led by Pitt Investigator ShowsA wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published in the New England Journal of Medicine. Advanced atrophic AMD, also known as geographic atrophy (GA), is the leading cause of irreversible blindness in older adults, affecting more than 5 million people worldwide.

Mental Exercise Can Reverse a Brain Change Linked to Aging, Study FindsScientists are reporting the first compelling evidence in people that cognitive training can boost levels of a brain chemical that typically declines with age. A 10-week study of people 65 or older found that doing rigorous mental exercises for 30 minutes a day increased levels of the chemical messenger acetylcholine by 2.3 percent in a…

Topcon Healthcare Launches IDHea, Inc. to Advance Drug Development and OculomicsLA JOLLA, Calif.—Topcon Healthcare, Inc., a global leader in digital health and ocular data solutions, has officially launched the Institute for Digital Health, or IDHea, Inc., a new company dedicated to transforming clinical research in eyecare and oculomics.

American Academy of Optometry Welcomes 2025 New Fellows and DiplomatesWINTER PARK, Fla.—During its recent Academy 2025 annual meeting earlier this month, the American Academy of Optometry announced that it has welcomed a record-breaking 329 new Fellows. Additionally, 11 existing Fellows were recognized with the esteemed title of Diplomate.

Ocuco Named as One of Ireland’s Best Managed Companies in 2025 by Deloitte for the Eighth TimeDUBLIN, Ireland—Ocuco announced that it has been named one of Ireland’s Best Managed Companies (BMC) by Deloitte for an eighth time. The company said it was recognized for its superior business performance as a platinum requalifying winner at an awards ceremony on September 25.

Global Study Reports Rise in Several Cancers Among Adults of All AgesIncidence of several cancers increased among adults of all ages in the past two decades, a global surveillance study found. From 2003-2017, incidence rates for six of 13 cancers assessed rose among younger adults (ages 20-49) in over 75 percent of the countries studied, reported Amy Berrington de Gonzalez, DPhil, of the Institute of Cancer…

WeightWatchers Partners With Amazon for Easy Weight-Loss Drug DeliveryAccording to Reuters, WeightWatchers said on Monday it will partner with Amazon to deliver medications including injectable GLP-1 obesity treatments for its members, driving the telehealth provider's shares up 9 percent as investors expected financial benefits from making it easier to fill prescriptions.

Optometry’s Expanding Scope: Bridging the Eyecare GapOptometry’s scope of practice expansion remains a vital and evolving issue. With an aging population as well as rising incidence of myopia, dry eye and diabetic eye disease driving up the demand for eyecare, optometrists in an increasing number of states are filling this vital health care need. Scope expansion is increasing patient access to…

STAAR Surgical Announces Preliminary Net Sales Increase for Third Quarter of 2025LAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA), a leading developer of phakic intraocular lenses with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, has announced preliminary net sales results for the third quarter ended September 26, 2025. The company reported preliminary net sales of $94.7 million, up 6.9 percent compared with…

Glaukos Receives FDA Approval of Epioxa for the Treatment of KeratoconusALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS) has announced that the U.S. Food and Drug Administration (FDA) approved its Epioxa HD/Epioxa New Drug Application (NDA) for the treatment of keratoconus.

Vision Scientist Teresa Puthussery, OD, Ph.D., Is Awarded MacArthur ‘Genius’ GrantBERKELEY, Calif.—Teresa Puthussery, OD, Ph.D., a neurobiologist and optometrist at the University of California, Berkeley, was named a 2025 MacArthur “Genius” Fellow on Oct. 8 for discoveries about how retinal cells encode visual information in the primate brain.

Eyecare Republic Announces Partnership With EyePromise to Advance Ocular Health and Practice GrowthPLANO, Texas—Eyecare Republic (ECR), a national network of independent optometrists, has announced a new partnership with EyePromise, a provider of science-backed nutritional and ocular surface wellness solutions.

U.S. Chamber of Commerce and U.S. Chamber of Commerce Foundation Launch Small Business B(AI)sics InitiativeWASHINGTON, D.C.—At its recent flagship event celebrating America’s small businesses, CO—100, the U.S. Chamber of Commerce announced the launch of Small Business B(AI)sics, a national training initiative designed to help entrepreneurs harness the power of artificial intelligence (AI) to grow their businesses and strengthen local economies. Developed in partnership with the U.S. Chamber of Commerce…

The Next Cancer-Fighting mRNA Vaccine May Already Be HereCOVID vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment.

Advice to Feed Babies Peanuts Early and Often Helped 60,000 Kids Avoid Allergies, Study FindsA decade after a landmark study proved that feeding peanut products to young babies could prevent development of life-threatening allergies, new research finds the change has made a big difference in the real world.

Topcon Healthcare Signs Acquisition Agreement for Toku, Inc. to Expand Oculomics Reach in EyecareLA JOLLA, Calif.—Topcon Healthcare Inc., a global leader in digital health and ocular data solutions, announced that it has signed a definitive agreement to acquire Toku, Inc., a San Diego-based artificial intelligence (AI) health technology company. Founded in New Zealand, Toku’s platforms, CLAiR, BioAge, and MyKidneyAI use standard color retinal images to assess cardiovascular risk,…

Optical Rockers to Perform on March 13 at Rock4Sight Fundraiser Concert in Orlando During Vision Expo 2026ORLANDO, Fla.—The collective of musicians and singers who perform under the Rock4Sight banner will perform at Blake Shelton’s Bar, Ole Red, on Friday, March 13, according to an announcement from organizers of the annual charity concert. Proceeds from the fundraiser will benefit ECN Purpose, a nonprofit that provides eyewear and eyecare for people in need.…

Prevent Blindness Kicks Off Fifth Annual Inflammatory Eye Disease WeekCHICAGO—Prevent Blindness has declared the week of Oct. 20 to 26, 2025, as the fifth annual Inflammatory Eye Disease (IED) Week. In observance of this awareness initiative, the group is offering a variety of free educational resources.

Southern College of Optometry Honors Three Alumni With AwardsMEMPHIS, Tenn.—Southern College of Optometry (SCO) announced late last week that it presented three alumni with awards during its 2025 Fall Homecoming and Continuing Education Weekend held in September.

Drug OD Deaths Rising for Ages 65+: What We KnowWhile drug overdose deaths overall have been falling recently, death rates for one surprising group continue to climb. The number of fentanyl-related deaths among people ages 65 and older have jumped nearly 1,500 percent since 2015, a new study found.

EssilorLuxottica Reports Record Q3 Revenue, Points to Wearables, Vision Care and SunglassesPARIS, France—EssilorLuxottica (Reuters: ESLX.PA) on Thursday reported record quarterly results, with consolidated revenue reaching €6,867 million for the third quarter of 2025, an 11.7 percent year-over-year increase at constant exchange rates compared with the third quarter of 2024. The company attributed this performance to robust demand for wearables, which they indicated provided a “major boost,…

Smartlens Secures $5.2 Million in Bridge Funding, Marked for FDA Clearance and Market Launch EffortsSUNNYVALE, Calif.—Smartlens, Inc., a clinical-stage ophthalmic technology company advancing next-generation glaucoma management devices, has announced the closing of an oversubscribed $5.2 million bridge round led by Ambit Health Ventures.

Heru Surpasses 1 Million Eyes Tested Using Its AI-Powered Wearable PlatformMIAMI, Fla.—Heru, a leader in artificial intelligence (AI)-powered vision diagnostics, announced it has surpassed a landmark achievement of one million eyes tested on its AI-powered wearable platform.

Orbis International Launches Ghana Eyecare Training ProjectNEW YORK—Global eyecare nonprofit Orbis International has launched the start of a training project this week in Ghana on board the Orbis Flying Eye Hospital, a fully accredited ophthalmic teaching hospital on a plane.

GlassesUSA.com Partners With The National Domestic Violence Hotline With ‘Aid to Cart’ Campaign for Purple ThursdayATLANTA—In recognition of Purple Thursday, a national day of action during Domestic Violence Awareness Month in the U.S. on October 16, online eyewear retailer GlassesUSA.com announced it has launched an awareness campaign called “Aid to Cart,” aimed at raising awareness of domestic violence and amplifying the lifesaving work of The National Domestic Violence Hotline. The…

Review of Optometry: Managing Binocular Vision and Pediatric Eye ConditionsCases of binocular dysfunction in children and adults are common. With increasing visual demands in modern life—particularly due to pervasive digital device use—recognition and management of these conditions have become more complex, and more important, than ever. While the diagnosis in these cases is often clear, clinicians may face challenges in selecting the most appropriate…

What to Know About Chikungunya VirusThis week, health officials in New York confirmed the first known locally acquired case of chikungunya virus, PBS News reports. Head over to PBS for more on this mosquito-borne illness.

Gene Therapy Restores Hearing for Rare Cause of Congenital DeafnessA novel gene therapy enabled children with congenital deafness due to otoferlin (OTOF) gene variants to hear for the first time, the pivotal phase I/II CHORD study showed.

Pickleball Peril? Eye Injuries Surge in Adults Over 50U.S. emergency departments saw more than 3,100 pickleball-related ocular injuries between 2005 and 2024, with 1,262 cases in 2024 alone, researchers estimated. Most of the eye injuries occurred in players over age 50 years.

EssilorLuxottica Announces Acquisition of Health Technology Company RetinAIPARIS—EssilorLuxottica (Reuters: ESLX.PA) announced yesterday that it has acquired Ikerian AG, a health technology company operating under the RetinAI brand, which specializes in artificial intelligence (AI) and data management in the eyecare sector. In making the announcement, the company advised that the move reinforces its “med-tech journey,” adding into its portfolio advanced software powered by…

EyePoint Pharmaceuticals Sets Pricing of Its Public Stock OfferingWATERTOWN, Mass.—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) announced it has priced an underwritten public offering of 11 million shares of common stock at $12.00 per share and pre-funded warrants to purchase up to 1.5 million additional shares.

The Vision Council Expands Networking Opportunities at Its 2026 Executive SummitALEXANDRIA, Va.—The Vision Council said Wednesday it has added new networking details for its 2026 Executive Summit, highlighting expanded opportunities for attendees to connect with industry leaders.

Protein Powders and Shakes Contain High Levels of LeadMuch has changed since Consumer Reports first tested protein powders and shakes. Over the past 15 years, Americans’ obsession with protein has transformed what had been a niche product into the centerpiece of a multibillion-dollar wellness craze, driving booming supplement sales and spawning a new crop of protein-fortified foods that now saturate supermarket shelves and…

Why Brittle Bones Aren’t Just a Woman’s ProblemRonald Klein was biking around his neighborhood in North Wales, Pennsylvania, in 2006 and tried to jump a curb. “But I was going too slow—I didn’t have enough momentum,” he recalled. As the bike toppled, he thrust out his left arm to break the fall. It didn’t seem like a serious accident, yet “I couldn’t…

Exercise and Pain: How to Move No Matter How Much You HurtPeople with chronic pain hear all about a fantasy world while living in a real one. From social media to headlines, that fantasy world has never been more in our faces.

Johnson & Johnson Reports 2025 Q3 Sales Growth, Raises Full-Year OutlookNEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) yesterday announced its third quarter 2025 financial results. The company reported year-over-year Q3 sales growth of 6.8 percent to $24.0 billion, with operational growth of 5.4 percent and adjusted operational growth of 4.4 percent.

Government Shutdown Week 3: Optical Industry Faces Potential FDA Slowdowns, New China Port FeesNEWARK, N.J.—As the federal government shutdown enters its third week, optical companies face a split reality. U.S. Customs remains largely operational, but constrained regulatory capacity, new port surcharges and lingering legal uncertainty over tariffs imposed under the International Emergency Economic Powers Act (IEEPA) are raising costs and could slow down shipments.

BVI’s Trifocal IOL Gains FDA Approval for U.S. MarketWALTHAM, Mass.—BVI, a global ophthalmic device company, announced that the Food and Drug Administration (FDA) has approved its FineVision HP trifocal intraocular lens (IOL) for the U.S. market. The company stated that FineVision HP is the world's first trifocal IOL, with over 15 years of clinical success and millions of implantations globally.

EssilorLuxottica Announces SWITCH: Vision Innovation Summit, a New Event Focused on the Future of Connected Health CarePARIS—EssilorLuxottica has announced the launch of “SWITCH: Vision Innovation Summit by EssilorLuxottica,” a new 3-day event exploring the driving forces behind the industry’s rapid transformation. The event will be held on March 9-11, 2026, in Orlando, Fla., for partners from the Americas, leading immediately into Vision Expo, and then again in Monte-Carlo, Monaco, on April 13-15,…

Alzheimer's Blood Test Cleared for Primary Care UseFDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary care setting, Roche announced on Monday.

Second Dose Boosts Shingles Protection in Adults Aged 65 Years or OlderThe recombinant herpes zoster vaccine is effective in older adults regardless of a patient’s immunocompromised status, based on data from more than 3 million adults aged 65 years or older. The recommended second dose further increased effectiveness against shingles.

The Optical Community Celebrates 25 Years of World Sight DayLONDON—Last week, the optical community celebrated the 25th anniversary of World Sight Day, the global awareness day observed annually on the second Thursday of October. This year's campaign, coordinated by the International Agency for the Prevention of Blindness (IAPB) in cooperation with the World Health Organization, focused on ensuring eyecare is accessible, available and affordable…

IDOC Launches Refreshed, Reimagined Brand IdentityNORWALK, Conn.—IDOC, an alliance for independent optometrists, today announces the launch of a refreshed brand identity and purpose-driven messaging platform. Designed to better serve independent ODs and build on the company’s mission of making independent ownership easier, the new brand ecosystem is anchored in the message “Independent Together,” the company said, and underscores its commitment…

Alcon Taking Steps to Relocate Two Manufacturing Lines From Europe to Its Fort Worth HeadquartersFORT WORTH, Texas—Global eyecare company Alcon is taking steps to relocate two manufacturing lines from Europe to its longstanding U.S. headquarters in Fort Worth, Texas, the company told VMAIL.

Registration Is Open for THE Myopia Meeting TorontoMARKHAM, Ontario—Jobson Optical Group and Review of Myopia Management today announced that based on its previous success and popularity, THE Myopia Meeting is returning to Canada, to the Hilton Toronto and Markham Suites Conference Center for a full-day event on Sunday, December 7, 2025.

Latest Edition of Contact Lens Update Explores Pre-Myopia Management Among CliniciansWATERLOO, Ontario—The Centre for Ocular Research & Education (CORE) has published the latest edition of Contact Lens Update, dedicated to rapidly accelerating interest in pre-myopia that is influencing risk assessment, early intervention, and myopia management among clinicians.

‘Exercise Snacks’ Can Improve Heart Fitness and Muscle Strength, New Research FindsShort bursts of purposeful activity—such as walking around the block or lifting small weights—may be the best way to get in the habit of exercising. Bite-sized bits of exercise also improve heart and muscle fitness, a study published Tuesday in BMJ Sports Medicine found.

WHO Warns of Widespread Resistance to Common Antibiotics WorldwideOne in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments, according to a new World Health Organization (WHO) report launched on October 13. Between 2018 and 2023, antibiotic resistance rose in over 40 percent of the pathogen-antibiotic combinations monitored, with an average annual increase of 5…

How Popular Diets Stack Up in Diabetes ManagementDietary advice for individuals with type 2 diabetes (T2D) is mainly grounded in common sense: Clinicians advise patients to eat in a way that controls their blood sugar, manages their weight, and makes them feel well.

Eyemart Express Donates Nearly $100,000 Worth of Eyewear to EyeCare4KidsYUMA, Ariz.—Leading national optical retailer Eyemart Express has announced that it is donating nearly $100,000 worth of new frames and glasses accessories to EyeCare4Kids, a nonprofit organization in Arizona that provides free eye exams and glasses to children in low-income communities across the state. Eyemart Express’ contribution, made in honor of World Sight Day on…

Foundation Fighting Blindness Marks World Mental Health Day With Upcoming Webinar for ECPsCOLUMBIA, Md.—The Foundation Fighting Blindness is recognizing World Mental Health Day, observed on October 10, by offering a free, one-hour webinar on Tuesday, November 11, for ECPs that highlights the critical role of mental health support in treating patients with retinal degenerative diseases.

Independent ECPs Weigh in on Scope of Practice Expansion in Vision Monday’s October Cover StoryNEWARK, N.J.—As rates of myopia, dry eye and diabetic eye disease climb across the U.S., demand for medical eyecare continues to increase. In the October 2025 issue, Vision Monday’s cover story “Optometry’s Expanding Scope: Bridging the Eyecare Gap” examines how independent optometrists are meeting patients’ needs, bringing in-office lasers, injections and minor surgical care to…

October’s Contact Lens Safety Month Puts the Emphasis on Proper Wear and CareWhen used under the guidance of an eyecare professional, contact lenses can be a safe and effective option for most patients, but by carefully following an eye doctor's instructions CL wearers can virtually eliminate the safety risks associated with contact lenses. This October, during "Contact Lens Safety Month," the 45 million Americans who use contact…

Amazon to Start Offering Prescription Drugs Through Vending MachinesAmazon announced it is rolling out "pharmacy kiosks" beginning in December. The self-service kiosks will allow Amazon's One Medical patients to bypass brick-and-mortar pharmacies and get their prescribed medications at the doctor's office at the end of their appointment.

Making Cancer Clinical Trials More Accessible: New Report Highlights Barriers and SolutionsClinical trials remain out of reach for many Americans, with only 7 percent of patients with cancer participating in clinical trials, according to a new report from the American Society of Clinical Oncology’s (ASCO) State of Cancer Care in America series.

California Aims to Improve School Nutrition by Phasing Out Some Ultraprocessed FoodsCalifornia will phase out certain ultraprocessed foods from school meals over the next decade under a first-in-the-nation law signed by Gov. Gavin Newsom. The law seeks to define ultraprocessed foods, the often super-tasty products typically full of sugar, salt and unhealthy fats. The legislation requires the state's Department of Public Health to adopt rules by…

The Vision Council Announces Keynote Speakers for Its 2026 Executive SummitALEXANDRIA, Va.—The Vision Council has announced it will feature several insightful keynote speakers at its 2026 Executive Summit taking place January 26-28, 2026, at The Ritz-Carlton, Amelia Island, Fla., including David Burkus, Dan Chuparkoff and Christopher Thornberg, Ph.D. Their presentations will focus on timely and relevant topics, the organization said, including AI, emotional intelligence, government…

Joshua Baker, OD, MS, to Present Keynote Address at NECO’s 2025 Industry Collaborative, Full Agenda Now AvailableBOSTON—The New England College of Optometry (NECO) has announced that Joshua Baker, OD, MS, the new president and CEO of Midwestern University, will present the opening keynote address at the 2025 Industry Collaborative on November 4.

Specsavers Canada Highlights National Vision Gap: One-Third of Canadians Are Overdue for an Eye Exam, Report SaysTORONTO—Specsavers Canada announced it has released the Canada Eyecare Report 2025, which reveals that one in three Canadian adults are overdue for an eye exam, with 17 percent reporting their last exam occurring more than five years ago.

Flu Season's Quiet Start May Be MisleadingExperts are predicting a moderate flu season—but that doesn't mean it's safe to ignore. "Last year, we saw high severity, and we are not expecting to have back-to-back [severe seasons]," said Adrienne Keen, Ph.D., of the CDC's Center for Forecasting and Outbreak Analytics.

Risks of Tramadol Likely Outweigh Benefit for Chronic PainThe opioid analgesic tramadol reduced chronic pain levels compared with placebo, but appeared to double the risk of harm, a review of 19 clinical trials suggested.

Today Is World Sight Day: Raising Global Awareness for Eye HealthLONDON—World Sight Day 2025 is being celebrated today, the second Thursday in October, as an annual global event emphasizing the vital importance of eyecare. This year's campaign, coordinated by the International Agency for the Prevention of Blindness (IAPB) in cooperation with the World Health Organization, focuses on ensuring eyecare is accessible, available, and affordable for…

KeraLink International Strengthens U.S. Vision Access With New PartnershipsBALTIMORE—KeraLink International (KLI), a nonprofit organization that is dedicated to making vision care affordable and accessible, has announced new partnerships with Saving KidSight, VOSH International, and the Johns Hopkins ViSION program.

Review of Ophthalmology: The Nuances of Mixed IOL StrategiesWhen first- and second-generation multifocal IOLs came onto the market, cataract surgeons often found themselves mixing and matching IOLs as a remedial measure to mitigate patient complaints, particularly related to dysphotopsias like glare and halos. However, with the evolution of more sophisticated IOL technology, this strategy has transformed from a reactive solution to a proactive,…

Management of uveitic and chorioretinal conditions in pregnancy Eye, Published online: 07 November 2025; doi:10.1038/s41433-025-04058-9Management of uveitic and chorioretinal conditions in pregnancy

Correction: New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway Eye, Published online: 07 November 2025; doi:10.1038/s41433-025-03971-3Correction: New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A/Nrp1 pathway

Correction: In vitro flow properties of Preserflo Microshunt with an intraluminal stent Eye, Published online: 07 November 2025; doi:10.1038/s41433-025-03958-0Correction: In vitro flow properties of Preserflo Microshunt with an intraluminal stent

Vitelliform lesions and choroidal changes in chorioretinal disorders: pathophysiological insights and clinical implications Eye, Published online: 06 November 2025; doi:10.1038/s41433-025-04103-7Vitelliform lesions and choroidal changes in chorioretinal disorders: pathophysiological insights and clinical implications

Intravitreal anti-VEGF therapy for extrafoveal macular neovascularisation secondary to age-related macular degeneration: five-year results in a tertiary centre Eye, Published online: 06 November 2025; doi:10.1038/s41433-025-04057-wIntravitreal anti-VEGF therapy for extrafoveal macular neovascularisation secondary to age-related macular degeneration: five-year results in a tertiary centre

The use of Janus kinase inhibitors to treat noninfectious uveitis Eye, Published online: 06 November 2025; doi:10.1038/s41433-025-04065-wThe use of Janus kinase inhibitors to treat noninfectious uveitis

Post-traumatic intracorneal cystEye, Published online: 05 November 2025; doi:10.1038/s41433-025-04108-2Post-traumatic intracorneal cyst

Infographic: early treatment with laser photocoagulation for retinopathy of prematurity (ETROP Study)Eye, Published online: 05 November 2025; doi:10.1038/s41433-025-04100-wInfographic: early treatment with laser photocoagulation for retinopathy of prematurity (ETROP Study)

Epicapsular pigment stars: a marker for gonio-dysgenesisEye, Published online: 05 November 2025; doi:10.1038/s41433-025-04107-3Epicapsular pigment stars: a marker for gonio-dysgenesis

Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort studyEye, Published online: 04 November 2025; doi:10.1038/s41433-025-04093-6Systemic prostacyclin analogues in pulmonary hypertension are associated with reduced risk of age-related macular degeneration: a cohort study

Neovascular glaucoma incidence and visual outcomes in treated proliferative diabetic retinopathy with anterior segment neovascularisationEye, Published online: 04 November 2025; doi:10.1038/s41433-025-04099-0Neovascular glaucoma incidence and visual outcomes in treated proliferative diabetic retinopathy with anterior segment neovascularisation

Deep learning algorithms for timely diagnosis of retinopathy of prematurity requiring treatmentEye, Published online: 03 November 2025; doi:10.1038/s41433-025-04096-3Deep learning algorithms for timely diagnosis of retinopathy of prematurity requiring treatment

From 1995 to now: the endophthalmitis vitrectomy study and the need for a contemporary evidence baseEye, Published online: 03 November 2025; doi:10.1038/s41433-025-04091-8From 1995 to now: the endophthalmitis vitrectomy study and the need for a contemporary evidence base

Pigmented chorioretinal scar in a child with blue rubber-bleb nevus syndromeEye, Published online: 03 November 2025; doi:10.1038/s41433-025-04098-1Pigmented chorioretinal scar in a child with blue rubber-bleb nevus syndrome

Posner-Schlossman syndrome and paracentral acute middle maculopathyEye, Published online: 03 November 2025; doi:10.1038/s41433-025-04101-9Posner-Schlossman syndrome and paracentral acute middle maculopathy

Transcription factor 4 and Fuchs’ endothelial corneal dystrophy (FECD) association: Perspectives for novel targeted therapeuticsEye, Published online: 02 November 2025; doi:10.1038/s41433-025-04106-4Transcription factor 4 and Fuchs’ endothelial corneal dystrophy (FECD) association: Perspectives for novel targeted therapeutics

Prevalence and temporal trends of vision impairment over two decades among those aged 40 years and older in Nagar Kurnool district in Telangana, IndiaEye, Published online: 01 November 2025; doi:10.1038/s41433-025-04090-9Prevalence and temporal trends of vision impairment over two decades among those aged 40 years and older in Nagar Kurnool district in Telangana, India

Infographic: FAME (fluocinolone acetonide for macular edema) trials of ILUVIEN® vitreous sustained-delivery inserts for diabetic macular oedemaEye, Published online: 31 October 2025; doi:10.1038/s41433-025-04088-3Infographic: FAME (fluocinolone acetonide for macular edema) trials of ILUVIEN® vitreous sustained-delivery inserts for diabetic macular oedema

Young-onset unilateral Terrien’s marginal degeneration: a rarity within rareEye, Published online: 31 October 2025; doi:10.1038/s41433-025-04094-5Young-onset unilateral Terrien’s marginal degeneration: a rarity within rare

Reply to age inaccuracies in an epidemiological study of paediatric and adult optic neuritisEye, Published online: 31 October 2025; doi:10.1038/s41433-025-04086-5Reply to age inaccuracies in an epidemiological study of paediatric and adult optic neuritis

Radiomics to predict high risk features in intraocular retinoblastomaEye, Published online: 27 October 2025; doi:10.1038/s41433-025-04009-4Radiomics to predict high risk features in intraocular retinoblastoma

Age inaccuracies in an epidemiological study of paediatric and adult optic neuritisEye, Published online: 26 October 2025; doi:10.1038/s41433-025-04085-6Age inaccuracies in an epidemiological study of paediatric and adult optic neuritis

Anti-vascular endothelial growth factor for the management of peripapillary choroidal neovascular membraneEye, Published online: 26 October 2025; doi:10.1038/s41433-025-04080-xAnti-vascular endothelial growth factor for the management of peripapillary choroidal neovascular membrane

Efficacy of Topical Tacrolimus (FK506) in High-risk Penetrating Keratoplasty: A Systematic Review and Meta-analysis of Comparative StudiesEye, Published online: 26 October 2025; doi:10.1038/s41433-025-04002-xEfficacy of Topical Tacrolimus (FK506) in High-risk Penetrating Keratoplasty: A Systematic Review and Meta-analysis of Comparative Studies

Metagenomic next-generation sequencing: a game-changer in the diagnosis of unique intraocular infectionsEye, Published online: 25 October 2025; doi:10.1038/s41433-025-04073-wMetagenomic next-generation sequencing: a game-changer in the diagnosis of unique intraocular infections

Indications for floaterectomy: results of a national BEAVRS surveyEye, Published online: 24 October 2025; doi:10.1038/s41433-025-04087-4Indications for floaterectomy: results of a national BEAVRS survey

Disappearance of iris nodules after trabeculectomyEye, Published online: 24 October 2025; doi:10.1038/s41433-025-04092-7Disappearance of iris nodules after trabeculectomy

Case series: Transient neonatal macular retinoschisis - a developmental phenomenon in term infantsEye, Published online: 23 October 2025; doi:10.1038/s41433-025-04082-9Case series: Transient neonatal macular retinoschisis - a developmental phenomenon in term infants

Assessment of the level of harm resulting from glaucoma progression due to review delayEye, Published online: 23 October 2025; doi:10.1038/s41433-025-04029-0Assessment of the level of harm resulting from glaucoma progression due to review delay

Endogenous endophthalmitis secondary to invasive <i>Klebsiella pneumoniae</i> liver abscess syndromeEye, Published online: 23 October 2025; doi:10.1038/s41433-025-04083-8Endogenous endophthalmitis secondary to invasive Klebsiella pneumoniae liver abscess syndrome

Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO studyEye, Published online: 23 October 2025; doi:10.1038/s41433-025-04059-8Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO study

Unaided reading speed in pseudophakic patients after emmetropic monofocal intraocular lens implantationEye, Published online: 23 October 2025; doi:10.1038/s41433-025-04048-xUnaided reading speed in pseudophakic patients after emmetropic monofocal intraocular lens implantation

What is the quality-of-life status of patients with keratoconus who have not had a surgical intervention? A systematic reviewEye, Published online: 22 October 2025; doi:10.1038/s41433-025-04053-0What is the quality-of-life status of patients with keratoconus who have not had a surgical intervention? A systematic review

Phenotypic characterisation of enhanced S Cone syndrome—a multicenter case series analysisEye, Published online: 22 October 2025; doi:10.1038/s41433-025-04077-6Phenotypic characterisation of enhanced S Cone syndrome—a multicenter case series analysis

Severe cytomegalovirus retinitisEye, Published online: 17 October 2025; doi:10.1038/s41433-025-04078-5Severe cytomegalovirus retinitis

Baseline factors that are associated with change in visual acuity in intermediate AMD over two years in a multicentre cohort study in Europe- INTERCEPT-AMD Report 2Eye, Published online: 17 October 2025; doi:10.1038/s41433-025-04062-zBaseline factors that are associated with change in visual acuity in intermediate AMD over two years in a multicentre cohort study in Europe- INTERCEPT-AMD Report 2

Associations between sleep patterns and diabetic retinopathy: insights from cross-sectional and longitudinal evidenceEye, Published online: 16 October 2025; doi:10.1038/s41433-025-04066-9Associations between sleep patterns and diabetic retinopathy: insights from cross-sectional and longitudinal evidence

Treatment intervals with first-generation anti-vascular endothelial growth factor drugs: evaluating the unmet need in a real-world neovascular age-related macular degeneration national databaseEye, Published online: 16 October 2025; doi:10.1038/s41433-025-03996-8Treatment intervals with first-generation anti-vascular endothelial growth factor drugs: evaluating the unmet need in a real-world neovascular age-related macular degeneration national database

Double trouble: exploring Oguchi disease with anomalous optic discEye, Published online: 16 October 2025; doi:10.1038/s41433-025-04067-8Double trouble: exploring Oguchi disease with anomalous optic disc

Correction: Accelerated aging in space and the ocular surfaceEye, Published online: 15 October 2025; doi:10.1038/s41433-025-04069-6Correction: Accelerated aging in space and the ocular surface

A 20-year review of orbital biopsy at the Newcastle Eye CentreEye, Published online: 15 October 2025; doi:10.1038/s41433-025-04079-4A 20-year review of orbital biopsy at the Newcastle Eye Centre

<i>MReye-Seg</i>: development and validation of an automated MRI pipeline for standardised ocular and orbital morphometricsEye, Published online: 14 October 2025; doi:10.1038/s41433-025-04044-1MReye-Seg: development and validation of an automated MRI pipeline for standardised ocular and orbital morphometrics

Infographic: Landmark trials in Neuro-Ophthalmology —results of the randomised sequential cross-over trial evaluating five purportedly ICP lowering drugs in idiopathic intracranial hypertensionEye, Published online: 14 October 2025; doi:10.1038/s41433-025-03946-4Infographic: Landmark trials in Neuro-Ophthalmology —results of the randomised sequential cross-over trial evaluating five purportedly ICP lowering drugs in idiopathic intracranial hypertension

Brown-McLean syndrome in traumatic aphakiaEye, Published online: 14 October 2025; doi:10.1038/s41433-025-04081-wBrown-McLean syndrome in traumatic aphakia

Sustainability practices made easyEye, Published online: 13 October 2025; doi:10.1038/s41433-025-04046-zSustainability practices made easy

Pathologic myopiaEye, Published online: 13 October 2025; doi:10.1038/s41433-025-04072-xPathologic myopia

Novel targets beyond vascular endothelial growth factor-A inhibition: improving vision with neovascular age-related macular degeneration treatmentEye, Published online: 11 October 2025; doi:10.1038/s41433-025-04042-3Novel targets beyond vascular endothelial growth factor-A inhibition: improving vision with neovascular age-related macular degeneration treatment

The effect of ethnicity on the accuracy of fundal reflex referralsEye, Published online: 11 October 2025; doi:10.1038/s41433-025-04070-zThe effect of ethnicity on the accuracy of fundal reflex referrals

Drug-related retinal detachment pharmacovigilance signals in the real world: evidence from the FDA Adverse Event Reporting SystemEye, Published online: 10 October 2025; doi:10.1038/s41433-025-04035-2Drug-related retinal detachment pharmacovigilance signals in the real world: evidence from the FDA Adverse Event Reporting System

Conjunctival histopathological changes associated with netarsudil 0.02%Eye, Published online: 09 October 2025; doi:10.1038/s41433-025-04063-yConjunctival histopathological changes associated with netarsudil 0.02%

Systemic Toxicity With Use of Apraclonidine Ophthalmic Drops in Pediatric Patients This case series attempts to identify and characterize postmarketing case reports reported to the US Food and Drug Administration and reported in the medical literature of systemic toxicity in pediatric patients who were administered apraclonidine ophthalmic drops.

High-Resolution Optical Coherence Tomography Correlates of Peau d’Orange in Pseudoxanthoma Elasticum This study attempts to identify high-resolution optical coherence tomography correlates of peau d’orange and continuously calcified Bruch membrane in patients with pseudoxanthoma elasticum.

Visual Outcomes and Complications Over 5 Years Following Lensectomy for Childhood Traumatic Cataract This cohort study reports visual acuity outcomes and cumulative incidence of ocular complications by 5 years following lensectomy for pediatric traumatic cataract.

Outcomes of Children With Primary Congenital Glaucoma Receiving Different Refractive Corrections This randomized clinical trial study compares the use of rigid gas-permeable contact lenses vs continued spectacle wear for improving visual outcomes for children after primary congenital glaucoma surgery.

Geographic Atrophy Multifocality in the Age-Related Eye Disease Study 2 This post hoc analysis of the Age-Related Eye Disease Study 2 (AREDS2) investigates the mean new geographic atrophy lesion incidence rate and what risk factors are associated with a faster rate.

Geographic Distribution and Coverage of US Neuro-Ophthalmologists This cross-sectional study examines the distribution and coverage of neuro-ophthalmologists in the US using drive time–based service area analysis.

Parsing the Heterogeneity of Geographic Atrophy Geographic atrophy (GA) is pathobiologically complex. Our limited understanding of the underlying molecular mechanisms is in part reflected in the high attrition rate of candidate therapies during clinical trial stages, as well as in the modest efficacy of those that are approved by the US Food and Drug Administration. Historically, most clinical trials have relied…

Pseudoxanthoma Elasticum and the Logic of its Ocular Manifestations Pseudoxanthoma elasticum (PXE) is a fascinating disease. Its hallmark clinical findings, salient changes in the skin, cardiovascular system, and eyes, seemed at odds with the biology of the causative gene-encoding adenosine-binding cassette protein C6, ABCC6, which is expressed predominantly in the liver and, to a lesser degree, the kidneys. The paradox of gene expression in…

Acute Unilateral Uveitis With Hypopyon and an Iris Lesion A previously healthy 31-year-old woman presents with acute unilateral anterior uveitis with hypopyon and an iris lesion and systemic symptoms, including headache, fatigue, and fever. What would you do next?

Retinal Sensitivity and Retinal Perfusion in Diabetic RetinopathyThis longitudinal cohort study conducted in the UK explores the association between retinal capillary nonperfusion and sensitivity in diabetic retinopathy.

Tofacitinib in Refractory Thyroid Eye DiseaseThis case report describes management of refractory thyroid eye disease in 2 patients using the Janus kinase 1/3 inhibitor tofacitinib.

Retinal Sensitivity in Areas of Retinal NonperfusionThe study by Hamilton-Perais and colleagues leveraged both ultra-widefield fluorescein angiography and static automated perimetric threshold to study the association of retinal sensitivity deficits with retinal capillary nonperfusion in people with diabetic retinopathy. Developing and validating end points is a priority to design clinical trials on interventions for retinal capillary nonperfusion. The strength of this…

Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 DiabetesThis secondary analysis of the J-DOIT3 randomized clinical trial examines the effects of an intensive multifactorial intervention and hypoglycemia on retinopathy in people with type 2 diabetes.

Optoretinography and Adaptive Optics Microperimetry in a Patient With AZOORThis report discusses a case of acute zonal outer occult retinopathy (AZOOR) that uses multimodal high-resolution imaging to demonstrate that the locus of vision loss initiates as early as phototransduction.

Neovascular Age-Related Macular Degeneration and GLP-1 RAs—ReplyIn Reply We read the letters with great interest commenting on our recent article. We agree that surveillance bias is a concern in observational studies using administrative data. To mitigate this, we implemented several methodological approaches. First, we used duration of diabetes as a covariate in propensity score matching, which serves as a proxy for…

Neovascular Age-Related Macular Degeneration and GLP-1 RAsTo the Editor We read with interest the study by Shor et al showing a 2-fold relative risk of newly diagnosed neovascular age-related macular degeneration (nAMD) among patients with type 2 diabetes prescribed glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment. Over a mean follow-up period of 2.4 years, the absolute risk of receiving a new…

Neovascular Age-Related Macular Degeneration and GLP-1 RAsTo the Editor A recent article by Shor et al reported a doubling (adjusted hazard ratio, 2.21; 95% CI, 1.65-2.96) in the risk of neovascular age-related macular degeneration (nAMD) associated with use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for diabetes in older adults, compared with patients with diabetes who never received GLP-1 RAs. While…

Neovascular Age-Related Macular Degeneration and GLP-1 RAsTo the Editor We read with interest the cohort study by Shor et al evaluating glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and incident neovascular age-related macular degeneration (nAMD). While the authors should be commended for leveraging Ontario’s administrative data to address an important pharmacovigilance question, the analysis does not appear to control for preexisting nonneovascular…

Neovascular Age-Related Macular Degeneration and GLP-1 RAsTo the Editor We read the recent report on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and incident neovascular age-related macular degeneration (nAMD) with interest. Given the expanding use of GLP-1 RAs and the need to monitor potential ocular adverse effects, such studies are welcome. However, we urge caution in interpreting associations derived from retrospective claims…

GLP-1RAs and AMD—Where Do We Stand?Ahuja and colleagues add to the growing literature on the impact of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on age-related macular degeneration (AMD). They present a retrospective cohort study of 45 704 matched patients performed using an electronic health records platform (TriNetX) evaluating the risk of developing nonexudative AMD and its progression to exudative AMD. Patients with…

Hypoglycemia, Glycemic Patterns, and Risk of Diabetic RetinopathyHyperglycemia is a well-established driver of diabetic retinopathy, with multiple randomized clinical trials demonstrating favorable retinopathy outcomes with improved glycemic control. Hemoglobin A1c reflects mean blood glucose levels over the preceding 2 to 3 months and is strongly associated with rates of microvascular complications, including diabetic retinopathy, neuropathy, and nephropathy. Regular hemoglobin A1c measurement is…

Glucagon-Like Peptide-1 Receptor Agonist and Age-Related Macular DegenerationThis cohort study assesses the association between glucagon-like peptide-1 receptor agonist use and the development or progression of age-related macular degeneration compared with other weight loss drugs for patients with overweight or obesity.

Using Big Data for Postmarket Safety SurveillanceSpontaneous adverse event (AE) reporting databases, such as the US Food and Drug Administration Adverse Event Reporting System (FAERS), provide publicly accessible data for nonclincal trial, real-time monitoring of the safety of approved medical products. They provide a valuable starting point for safety signal detection, especially for toxic effects (such as retinal toxic effects of…

Systemic Drugs Associated With MaculopathyThis study examines data to identify systemic drugs potentially associated with maculopathy via pharmacovigilance reporting and evaluates their macular adverse effects in a nationwide encounter database.

Endothelial Cell Loss 1 Year After Successful DMEKThis randomized clinical trial investigates if endothelial cell loss and morphometric changes 1 year after successful Descemet membrane endothelial keratoplasty (DMEK) are associated with the presence of diabetes in a cornea donor.

Donor Diabetes and 1-Year DMEK Success RateThis randomized clinical trial investigates if the presence of diabetes in a cornea donor affects the success of Descemet membrane endothelial keratoplasty (DMEK) at 1 year postoperatively.

Impact of the Diabetes Endothelial Keratoplasty StudyAs the prevalence of diabetes increases in the population and thus in the corneal transplant donor pool, there has been increased interest in understanding how the diabetic status of the donor affects graft outcomes. The Diabetes Endothelial Keratoplasty Study (DEKS) provides the strongest evidence to date, to our knowledge, for addressing this question. The DEKS…

Unifying Diagnosis of Choroidal Indeterminate Melanocytic TumorsTo the Editor While Singh et al have tackled a worthwhile subject with statistical rigor, there are some study limitations that may be worth emphasizing for practicing ophthalmologists. Central to the question of malignant transformation is the definition of choroidal nevus vs choroidal melanoma. Unfortunately, definitive, objective diagnoses are lacking in a tumor that is…

Retinal Imaging Considerations After RLRL Treatment for MyopiaTo the Editor Regarding the recent report by Liao and coauthors on changes following repeated low-level red light (RLRL) treatment for myopia, I question the validity of the conclusions drawn. The reported cone densities in control eyes at the most central locations (<0.5-mm eccentricity) deviate from what is established as normal based on histological preparations…

Retinal Imaging Considerations After RLRL Treatment for MyopiaTo the Editor We were interested in the report by Liao et al on cone density changes after repeated low-level red light (RLRL) treatment in children with myopia. The study found decreased parafoveal cone densities and increased abnormal cell signals near the fovea in RLRL users, raising concerns about potential retinal abnormalities and long-term safety.…

Benefits and Limitations of Using Population Databases for Eye ResearchCompared with single or multicenter studies, health-related data repositories increase the scale, scope, and power of research aimed at identifying trends in ocular conditions across demographic groups, geographic regions, and time periods. Research using such databases has numerous advantages; however, it is important to also understand its limitations.

Transforming Ophthalmic Education With Large Language ModelsSwift advancements in large language models (LLMs) are transforming ophthalmic education, moving beyond traditional teaching methods toward more dynamic and personalized learning approaches. In their recent study, Gholami and colleagues showcased a novel advancement in the use of LLMs for ophthalmic education by demonstrating that ophthalmology board–style multiple choice questions (MCQs) generated by OpenAI’s GPT-4o…

Residual PFO Following Surgery for Persistent Fetal VasculatureAn 11-day-old boy was referred for evaluation of right eye leukocoria and was diagnosed with persistent fetal vasculature. Fundus photographs revealed perfluoro-n-octane bubbles in the inferior retina, and optical coherence tomography showed good foveal contour, no macular edema or epiretinal membrane, and final best-corrected visual acuity of 20/300 in the right eye. What would you…

Pickleball-Related Ocular Injuries Presenting to Emergency DepartmentsThis cross-sectional study asseses incidence of and demographic factors associated with pickleball-related ocular injuries over the past 20 years

Leveraging Large Language Models to Generate Multiple-Choice Questions for Ophthalmology EducationThis survey study evaluates whether general-domain large language models can reliably generate high-quality, novel, and readable multiple-choice questions that are comparable to those of a committee of experienced examination writers.

Retinal Imaging Considerations After RLRL Treatment for Myopia—ReplyIn Reply We appreciate the concerns regarding cone density measurements in our study. Of note, our measurements are consistent with other literature on this topic. The study by Wang et al (cited by Dr Harmening) directly references that by Chui et al, who reported 27 712 cones/mm2 at 0.3-mm eccentricity—similar to our findings. Furthermore, the density…

Unifying Diagnosis of Choroidal Indeterminate Melanocytic Tumors—ReplyIn Reply Dr Dalvin has correctly pointed out limitations in generating high-quality data due to lack of diagnostic biopsy in cases of uveal melanoma in general (conventional practice pattern) and, more specifically, in small choroidal melanoma. Therefore, the diagnosis of large choroidal nevus or small choroidal melanoma (indeterminate melanocytic tumors [IMTs]) continues to be subjective,…

Retinal Imaging Considerations After RLRL Treatment for MyopiaTo the Editor I read with interest the recent article by Liao et al, “Cone Density Changes After Repeated Low-Level Red Light Treatment in Children With Myopia.” While the study addresses a timely topic using multiple imaging modalities, I would like to raise a concern regarding the interpretation of imaging findings presented in their Figure…

IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese PatientsThis randomized clinical trial evaluates the safety and efficacy of the insulin-like growth factor 1 receptor IBI311 in Chinese patients with thyroid eye disease.

Predicting Spaceflight-Associated Neuro-Ocular Syndrome in International Space Station AstronautsThis cohort study analyzes spaceflight-associated neuro-ocular syndrome (SANS) data among NASA astronauts who have completed 2 long-duration spaceflights to determine mission-to-mission trends in SANS diagnosis and optic disc edema severity.

Expanding the Potential Treatment of Thyroid Eye DiseaseThe Registration Study of IBI311 in Thyroid Eye Disease (RESTORE-1) study by Zhang et al represents a vital contribution to the evolving therapeutic landscape of thyroid eye disease (TED). This phase 3, placebo-controlled, randomized clinical trial evaluates the efficacy and safety of IBI311, a treatment targeting the insulin-like growth factor 1 receptor (IGF-1R), in Chinese…